Key facts
- This page summarizes Chen Schor's Form 4 filing for Adicet Bio, Inc. (ACET).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Jan 2025, 16:29.
Chen Schor - 24 Jan 2025 Form 4 Insider Report for Adicet Bio, Inc. (ACET)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- ACET
- Reported as of
- 24 Jan 2025
- Net transaction value
- -$25,904
- SEC form
- 4
- Accepted by SEC
- 28 Jan 2025, 16:29:04 UTC
- Prior SEC filing
- 07 Jun 2024
- Next SEC filing
- 04 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nick Harvey, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Chen Schor filed Form 4 for Adicet Bio, Inc. (ACET) on 28 Jan 2025.
Change
- Previous filing in this sequence was filed on 07 Jun 2024.
- Current net transaction value: -$25,904.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACET
transaction
Common Stock
Tax liability
- Transaction value
- $25,904
- Shares
- -28,101
- Change %
- -17%
- Price
- $0.9218
- Shares after
- 137,201
- Date
- 24 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
ACET
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 43,469
- Date
- 24 Jan 2025
- Ownership
- See Footnote
- Footnotes
- F2
ACET
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 53,424
- Date
- 24 Jan 2025
- Ownership
- See Footnote
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
Footnote F2
Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee.
Footnote F3
Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.
SEC remarks
The number of securities beneficially owned as reported in each column (5) reflects ownership as of the date of this filing based on available records of the Reporting Person and other information provided to the Issuer and reflects the correct allocation of the Reporting Person's shares among various accounts. Prior Form 4 filings made by the Reporting Person on October 2, 2023 and January 24, 2024 inadvertently overstated the aggregate number of securities beneficially owned by Reporting Person by 43,469 shares. The Reporting Person has corrected the inadvertent overstatement in this Form 4 filing across applicable accounts.